Big things are happening recently with Creso Pharma (ASX: CPH) (OTC: COPHF) (FRA: 1X8), most notably the closing of the company’s acquisition of Canadian psychedelics firm Halucenex Life Sciences and the major announcement that saw Canopy Growth (TSX: WEED) (NASDAQ: CGC) (FRA: 11L1) founder and former CEO Bruce Linton confirm that he will be joining The HighBrid Lab following the completion of the Creso Pharma Red Light Holland (CSE: TRIP) (OTC: TRUFF) (FRA: 4YX) merger.
In even bigger news, on Monday, Creso announced that its wholly-owned psychedelics subsidiary, Halucenex secured the highly sought-after Controlled Drugs and Substances Dealer’s Licence from Health Canada. As one of the few companies worldwide with a Dealer’s Licence, Halucenex can now possess, sell, transport and conduct R&D on a range of psychedelics, such as psilocybin, ketamine, LSD and MDMA.
This news is a milestone achievement for Halucenex as the Creso Pharma-owned psychedelics firm can now move forward with its planned phase II clinical trial, which will seek to test the efficacy of psilocybin on treatment-resistant post-traumatic stress disorder (PTSD).
Stay tuned for further updates on Creso Pharma, Halucenex and the soon-to-be The HighBrid Lab.
For more information on these companies, please check out the research materials below:
- Click Here to Read the Creso Pharma + Red Light Holland = The HighBrid Lab Investor Presentation
- Click here to Read the Halucenex Life Sciences Investor Presentation
Learn more about Creso Pharma: Website | IR Website | Investor Deck | CPH Chart
- Creso Pharma’s Halucenex Continues to Make Strong Progress in Psychedelics Industry Ahead of Phase II Clinical Trials
- Creso Pharma Closes Halucenex Psychedelics Acquisition, Bruce Linton to Become Chairman of The HighBrid Lab
- Creso Pharma to Merge With Psychedelics Leader Red Light Holland, Combined Company Set to Become a Cannabis and Psychedelics Industry Juggernaut
With U.S. Pot Stocks the Hot Theme of 2021, Here’s Why Red White & Bloom Could Be One of the Cannabis Sector’s Top Performers
Follow TCI on Social Media: Facebook | Instagram | Twitter | LinkedIn | Investor Group
Follow Psychedelic Profits on Social Media: Facebook | Twitter | LinkedIn | Investor Group
Get Your Copy of The Ultimate Cannabis Investing Guide
Join the Discussion in the TCI Investor Group
Creso Pharma is a paid client of The Cannabis Investor. The Cannabis Investor does not hold a position in CPH.
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.
Read More:
Featured ArticlesCannabis Stock NewsCannabis Industry ArticlesTechnical Analysis ArticlesWatch Cannabis Stock Videos